governance and ethics

infirst Ltd is 100% owned by Flarin Holdings Ltd which is a UK company owned by private investors. The business is managed by a Leadership Team with many decades of industry experience. This team strive to manage the business through the development and application of consistent and cohesive policies, guidelines, processes and decision making authorities. The Leadership Team is accountable to the Board of Directors of Flarin Holdings Ltd, the members of which are listed below.

Board members

Manfred Scheske

Manfred is Non-Executive Director and Chairman of infirst Limited’s parent company, Flarin Holding Ltd. Manfred was previously CEO of the Infirst Healthcare Group and spent 25 highly successful years with GlaxoSmithKline Consumer Health including commercial responsibilities for Europe and North America. Manfred has given long service to industry associations having been on the Boards of CHPA in the USA, AESGP in Europe and PAGB in the UK. Manfred holds further non-executive Board roles in the USA, Germany and Scandinavia.

Andrew Macmillen
Managing Director

Andrew has over 30 years of experience in managerial roles in Pharmaceuticals and Consumer Healthcare including over 10 years as a Vice President Consumer Healthcare for Latin America, and Central and Eastern Europe in GSK. He worked with infirst Healthcare Limited as a consultant responsible for Business Development and Flarin before taking up his current position in November 2019. He is a graduate of Durham and Hull Universities.

Philip Lindsell
Chief Financial Officer

Philip joined Infirst Healthcare as Chief Financial Officer in November 2018 and was appointed Chief Financial Officer for infirst Limited in October 2019. He is a chartered accountant and has been CFO of a variety of public and privately owned companies since 1990. Philip is an engineering graduate of Oxford University and started his career at Deloitte Haskins & Sells in London and in the oil and energy industries in financial management, commercial and consultancy roles.

Alan Armstrong
Non-Executive Director

Alan is a Non-Executive Director of Flarin Holdings Limited, working with the management team and managing IW Capital’s investment in the Company. He is the Head of Investment at IW Capital and Chair of its Investment Committee. He sits on the Board of a number of its portfolio investments, working closely with the management teams. He has over 30 years of experience as a private equity professional and is a former director of NatWest Equity Partners (Bridgepoint Capital) prior to buying into and managing a PE backed group of international businesses. He read Economics and Accounting at Newcastle University and has been a member of the Chartered Institute for Securities and Investment for over 20 years

Richard Huston
Non-Executive Director

Richard has over 30 years’ experience in the Financial Industry and in that time has held Executive roles in Asia, Europe and the UK. He has been involved in start-ups and small businesses in both the UK and the US and is currently MD of Seek Group, a pharmaceutical company and holds several related Directorships in Biotech, Including StageZero Life Sciences.

Robin Lincoln
Non-Executive Director

Robin is a portfolio operating partner at Hambro Perks. He has over 20 years of private equity and venture capital experience, working with portfolio companies to achieve their full potential. Robin’s prior experience includes head of the venture portfolio at Oxford Capital, head of business services practice at HgCapital, part of the equity restructure team at Lloyds Bank and investment director at Living Bridge. He has served on more than 40 boards for investors and is a qualified chartered accountant.

25% of British people - wait until something is "seriously wrong" before seeing their GP
25% of British people

wait until something is "seriously wrong" before seeing their GP